KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Total Debt (2016 - 2025)

LifeMD filings provide 6 years of Total Debt readings, the most recent being $12.0 million for Q2 2025.

  • On a quarterly basis, Total Debt rose 88.85% to $12.0 million in Q2 2025 year-over-year; TTM through Jun 2025 was $12.0 million, a 88.85% increase, with the full-year FY2024 number at $8.4 million, changed N/A from a year prior.
  • Total Debt hit $12.0 million in Q2 2025 for LifeMD, up from $11.6 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $12.0 million in Q2 2025 to a low of $4.0 million in Q1 2024.
  • Median Total Debt over the past 3 years was $8.8 million (2021), compared with a mean of $8.5 million.
  • The widest YoY moves for Total Debt: up 193.33% in 2025, down 88.85% in 2025.
  • LifeMD's Total Debt stood at $10.8 million in 2021, then dropped by 21.95% to $8.4 million in 2024, then surged by 41.64% to $12.0 million in 2025.
  • The last three reported values for Total Debt were $12.0 million (Q2 2025), $11.6 million (Q1 2025), and $8.4 million (Q4 2024) per Business Quant data.